J Natl Cancer Inst 1996, 88:1222–1227.PubMedCrossRef 17. Cao M, Yie SM, Wu SM, Chen S, Lou B, He X, Ye SR, Xie K, Rao L, Gao E, Ye NY: Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous selleck cell carcinoma and its clinical significance. Clin Exp Metastasis 2009, 26:751–758.PubMedCrossRef 18. Wagner GF, Jaworski EM, Haddad M: Stanniocalcin in the seawater salmon: structure, function, and regulation. Am J Physiol 1998, 274:R1177-R1185.PubMed 19. Deol HK, Varghese R, Wagner GF, Dimattia GE: Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation. Endocrinology
2000, 141:3412–3421.PubMedCrossRef 20. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC: Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci USA 2000, 97:3637–3642.PubMedCrossRef
21. Nguyen A, Chang AC, Reddel RR: Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway PF-6463922 clinical trial during oxidative stress. Oncogene 2009, 28:1982–1992.PubMedCrossRef 22. He LF, Wang TT, Gao QY, Zhao GF, Huang YH, Yu LK, Hou YY: Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells. J Biomed Sci 2011, 18:39.PubMedCrossRef 23. Chang AC, Jellinek DA, Reddel RR: Mammalian stanniocalcins and cancer. Endocr Relat Cancer 2003, 10:359–373.PubMedCrossRef 24. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in this website viral carcinogenesis and tumor progression. Cancer Res 2001, 61:2129–2137.PubMed 25. Fujiwara Y, Sugita Y, Nakamori S, Miyamoto A, Shiozaki K, Nagano H, Sakon M, Monden M: Assessment of Stanniocalcin-1
mRNA as a molecular marker for micrometastases of various human cancers. Int J Oncol 2000, 16:799–804.PubMed 26. Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O’Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S: Metastatic susceptibility locus, an 8p CFTRinh-172 supplier hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer 2008, 8:187.PubMedCrossRef 27. Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J, Bast RC, Lin SH, Liu J: Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst 2010, 102:812–827.PubMedCrossRef 28. McCudden CR, Majewski A, Chakrabarti S, Wagner GF: Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas. Mol Cell Endocrinol 2004, 213:167–172.PubMedCrossRef 29. Watanabe T, Ichihara M, Hashimoto M, Shimono K, Shimoyama Y, Nagasaka T, Murakumo Y, Murakami H, Sugiura H, Iwata H, Ishiguro N, Takahashi M: Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. Am J Pathol 2002, 161:249–256.PubMedCrossRef 30.